Real-time enrollment status for this refractory lupus nephritis clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 4:38 AM UTC
| NCT Number | NCT07403188 |
| Recruiting Status | Recruiting |
| Condition | Refractory Lupus Nephritis |
| Phase | Clinical Trial |
| Target Enrollment | 70 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Kyverna Therapeutics |
| Last Updated on CT.gov | February 11, 2026 (Feb 11, 2026) |
As of July 20, 2026: Clinical trial NCT07403188 is currently recruiting participants. This clinical trial study for refractory lupus nephritis is actively seeking new participants at 1 location across the United States. The study is sponsored by Kyverna Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07403188 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07403188 was last updated Feb 11, 2026 (February 11, 2026). HelloStudys verifies this status automatically.